Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04793581 · ClinicalTrials.gov registry record · NA

Assessment of the Utility of the Pantheris Small Vessel (SV) System

A NA study of Peripheral Arterial Disease, sponsored by Avinger.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT04793581 is a NA study of Peripheral Arterial Disease that is actively recruiting participants, run by Avinger. The registered enrollment target is 60 participants, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04793581, a NA study of Peripheral Arterial Disease, is actively recruiting participants, sponsored by Avinger.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

A single-arm study to assess the utility of the Pantheris SV catheter in addressing peripheral artery disease in arteries located below the knee. Data will be collected on the percent stenosis pre- and post-atherectomy and then symptoms and adverse events noted at 30 days, 6 months, and 1 year after the procedure.

Interventions

  • DEVICE Atherectomy

Study Locations (2)

Michigan

  • Advanced Cardiac and Vascular Centers - Grand Rapids
  • Eastlake Cardiovascular PC - Saint Clair Shores

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-01-29
Est. Completion 2025-08-01
Phase NA

Sponsor

Avinger

6 total trials

What the Registry Record Tells You About NCT04793581

The ClinicalTrials.gov registry entry for NCT04793581 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The listed sponsor is Avinger, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Atherectomy is the first listed.

NCT04793581 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04793581 about?

NCT04793581 is a clinical study titled "Assessment of the Utility of the Pantheris Small Vessel (SV) System". A single-arm study to assess the utility of the Pantheris SV catheter in addressing peripheral artery disease in arteries located below the knee. Data will be collected on the percent stenosis pre- and post-atherectomy and then symptoms and adverse events noted at 30 days, 6 months, and 1 year after...

What is the current status of trial NCT04793581?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-01-29. Estimated completion is 2025-08-01.

What conditions does trial NCT04793581 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease.

What interventions are being tested in trial NCT04793581?

The interventions under investigation include: Atherectomy (DEVICE).

Who is sponsoring clinical trial NCT04793581?

This trial is sponsored by Avinger, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04793581 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.